Clavis Pharma Raises $20 Million

Clavis Pharma ASA (OSE: CLAVIS), an Oslo-based oncology drug company, has raised around $20 million via a private placement of 10.75 million shares. Buyers included existing shareholders NeoMed Management and MVM Life Science Partners.

North AmericaUSBriefs